Detalhe da pesquisa
1.
An atlas of healthy and injured cell states and niches in the human kidney.
Nature
; 619(7970): 585-594, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468583
2.
Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.
N Engl J Med
; 390(13): 1196-1206, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598574
3.
Protein N-glycans in Healthy and Sclerotic Glomeruli in Diabetic Kidney Disease.
J Am Soc Nephrol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38771634
4.
Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT.
Circulation
; 147(4): 310-323, 2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533535
5.
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKD.
Ann Intern Med
; 176(1): 59-66, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36469914
6.
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials.
J Am Soc Nephrol
; 34(12): 1965-1975, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37876229
7.
Prediction of Mortality and Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury.
Am J Kidney Dis
; 81(1): 36-47, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35868537
8.
Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD.
J Am Soc Nephrol
; 33(11): 2094-2107, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977807
9.
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial.
Diabetologia
; 65(7): 1085-1097, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445820
10.
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.
Kidney Int
; 101(1): 174-184, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34560136
11.
Assessment of a modified renal angina index for AKI prediction in critically ill adults.
Nephrol Dial Transplant
; 37(5): 895-903, 2022 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33605426
12.
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial.
Nephrol Dial Transplant
; 37(9): 1647-1656, 2022 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34850160
13.
Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease.
Diabetes Obes Metab
; 24(5): 827-837, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34984791
14.
Serum IL-17 levels are higher in critically ill patients with AKI and associated with worse outcomes.
Crit Care
; 26(1): 107, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35422004
15.
Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease.
J Am Soc Nephrol
; 32(9): 2352-2361, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272327
16.
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.
Eur Heart J
; 42(13): 1216-1227, 2021 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792669
17.
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy.
Kidney Int
; 100(1): 215-224, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33878338
18.
Rationale and design of the Kidney Precision Medicine Project.
Kidney Int
; 99(3): 498-510, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33637194
19.
Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study.
Crit Care
; 25(1): 294, 2021 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34391450
20.
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
Circulation
; 139(3): 351-361, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30586723